16. クロウ・深瀬症候群 Crow-Fukase syndrome Clinical trials / Disease details
臨床試験数 : 13 / 薬物数 : 14 - (DrugBank : 7) / 標的遺伝子数 : 4 - 標的パスウェイ数 : 75
Showing 1 to 10 of 13 diseases
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | ChiCTR2200056637 | 2022-02-08 | 2022-02-09 | A multicenter, open and exploratory clinical study of pomadomide combined with dexamethasone in the treatment of newly diagnosed POEMS syndrome A multicenter, open and exploratory clinical study of pomadomide combined with dexamethasone in the ... | A multicenter, open and exploratory clinical study of pomadomide combined with dexamethasone in the treatment of newly diagnosed POEMS syndrome A multicenter, open and exploratory clinical study of pomadomide combined with dexamethasone in the ... | Multiple myeloma | Pd:Pomadomide combined with dexamethasone in the treatment of patients with newly diagnosed POEMS syndrome ; Pd:Pomadomide combined with dexamethasonein the treatment of patients with newly diagnosed POEMS syn ... | Qingdao Municipal Hospital | NULL | Recruiting | 18 | 100 | Both | Pd:30; | Phase 4 | China |
2 | NCT05263817 (ClinicalTrials.gov) | October 8, 2021 | 1/12/2021 | A Clinical Study of CD19/BCMA CAR-T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia, and Vasculitis A Clinical Study of CD19/BCMA CAR-T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis ... | A Clinical Study on the Safety and Effectiveness of CD19/BCMA Chimeric Antigen Receptor T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia, and Vasculitis A Clinical Study on the Safety and Effectiveness of CD19/BCMA Chimeric Antigen Receptor T Cells in t ... | POEMS Syndrome;Amyloidosis;Autoimmune Hemolytic Anemia;Vasculitis | Biological: CD19/BCMA CAR T-cells | Zhejiang University | Yake Biotechnology Ltd. | Recruiting | N/A | N/A | All | 75 | Early Phase 1 | China |
3 | NCT02921893 (ClinicalTrials.gov) | October 31, 2016 | 26/9/2016 | Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome | Ixazomib, Lenalidomide, and Dexamethasone for Patients With POEMS Syndrome | Plasmacytoma;POEMS Syndrome | Drug: Dexamethasone;Drug: Ixazomib Citrate;Drug: Lenalidomide;Other: Questionnaire Administration | Mayo Clinic | National Cancer Institute (NCI) | Active, not recruiting | 18 Years | N/A | All | 21 | Early Phase 1 | United States |
4 | JPRN-jRCTs031180421 | 15/08/2016 | 25/03/2019 | LDCY-POEMS study | Phase II study of efficiency of peripheral blood stem cell harvest using low-dose cyclophosphamide plus G-CSF for POEMS syndrome Phase II study of efficiency of peripheral blood stem cell harvest using low-dose cyclophosphamide p ... | POEMS syndrome POEMS syndrome | Treatment by cyclophosphamide, mesna, graniserton, and lenograstim. Autologous peripheral blood stem cell harvest (auto-PBSCH) Treatment by cyclophosphamide, mesna, graniserton, and lenograstim. Autologous peripheral blood stem ... | Sakaida Emiko | NULL | Recruiting | >= 20age old | <= 70age old | Both | 14 | Phase 2 | Japan |
5 | JPRN-UMIN000018660 | 2015/08/17 | 17/08/2015 | Japanese POEMS syndrome with thalidmaide trial for compassionate use | Japanese POEMS syndrome with thalidmaide trial for compassionate use - Japanese POEMS syndrome with thalidmaide trial for compassionate use (JPOST15) Japanese POEMS syndromewith thalidmaide trial for compassionate use - Japanese POEMS syndromewith th ... | Crow-Fukase(POEMS) syndrome | FPF300 (thalidomide)100-300mg/day,at bedtime +Dexamethasone 20mg/day (day1-4) Duration:until the approval of thalidomide for POEMT syndrome FPF300 (thalidomide)100-300mg/day,at bedtime +Dexamethasone20mg/day (day1-4) Duration:until the appro ... | Chiba University Graduate School of Medicine | NULL | Complete: follow-up complete | 20years-old | Not applicable | Male and Female | 20 | Not selected | Japan |
6 | JPRN-UMIN000018385 | 2015/07/01 | 22/07/2015 | Phase II study of efficiency of peripheral blood stem cell harvest in POEMS syndrome patients with low-dose cyclophosphamide plus G-CSF Phase II study of efficiency of peripheral blood stem cell harvest in POEMS syndromepatients with lo ... | Phase II study of efficiency of peripheral blood stem cell harvest in POEMS syndrome patients with low-dose cyclophosphamide plus G-CSF - Phase II study of efficiency of peripheral blood stem cell harvest in POEMS syndrome patients with low-dose cyclophosphamide plus G-CSF Phase II study of efficiency of peripheral blood stem cell harvest in POEMS syndromepatients with lo ... | POEMS syndrome | This study is composed of the following two steps of therapy. 1)PBSC mobilization using low dose cyclophosphamide and G-CSF 2)autologous peripheral stem cell transplantation after high dose chemotherapy This study is composed of the following two steps of therapy. 1)PBSC mobilization using low dose cyc ... | Chiba University HospitalDepartment of Hematology | NULL | Pending | 20years-old | 70years-old | Male and Female | 14 | Phase 2 | Japan |
7 | NCT02193698 (ClinicalTrials.gov) | July 2014 | 16/7/2014 | Efficacy and Safety of Lenalidomide as a Treatment for Recurrent or Refractory POEMS Syndrome Trial | Single Arm Open-label Trial to Investigate the Efficacy and Safety of Lenlidomide as a Treatment for Recurrent or Refractory Crow-Fukase (POEMS) Syndrome Single Arm Open-label Trial to Investigate the Efficacy and Safety of Lenlidomide as a Treatment for ... | POEMS Syndrome | Drug: Lenalidomide+Dexamethasone | Chiba University | NULL | Completed | 20 Years | N/A | Both | 5 | Phase 2 | Japan |
8 | NCT01816620 (ClinicalTrials.gov) | March 2014 | 14/3/2013 | Study to Evaluate Lenalidomide Plus Dexamethasone in Patients With Newly Diagnosed POEMS Syndrome | An Open-label Phase II Study to Determine the Efficacy and Safety of Lenalidomide Plus Dexamethasone (LDex) in Patients With Newly Diagnosed POEMS Syndrome An Open-label Phase II Study to Determine the Efficacy and Safety of Lenalidomide Plus Dexamethasone ... | POEMS Syndrome | Drug: Lenalidomide, Dexamethasone | Peking Union Medical College Hospital | Celgene Corporation | Completed | 18 Years | N/A | All | 41 | Phase 2 | China |
9 | NCT01639898 (ClinicalTrials.gov) | July 2012 | 5/7/2012 | POEMS Syndrome Treatment With Lenalidomide | Phase II Trial With Lenalidomide-Dexamethasone Combination in the Treatment of POEMS Syndrome. | POEMS Syndrome | Drug: Lenalidomide and dexamethasone | University Hospital, Limoges | Ministry of Health, France;Celgene Corporation | Completed | 18 Years | N/A | All | 51 | Phase 2 | France |
10 | JPRN-JMA-IIA00084 | 22/03/2012 | 19/03/2012 | Japanese POEMS Syndrome with Thalidomide Trial | Japanese POEMS Syndrome with Thalidomide Trial | Crow-Fukase (POEMS) syndrome | Intervention type:DRUG. Intervention1:FPF 300 (thalidomide), Dose form:CAPSULE, Route of administration:ORAL. Intervention type:DRUG. Intervention1:FPF 300 (thalidomide), Dose form:CAPSULE, Route of administrat ... | J-POST Clinical Trial Office | Hokkaido University, Hokkaido Medical Center, Tohoku University, Chiba University, Saitama Medical University, Niigata University, Shinshu University, Nagoya University, Kinki University, Kobe City Medical Center General Hospital, Yamaguchi University, Kyushu University, Kagoshima University Hokkaido University, Hokkaido Medical Center, Tohoku University, Chiba University, Saitama Medical U ... | Completed | >=20 YEARS | No Limit | BOTH | 24 | Phase 3 | Japan |